quinolinic acid has been researched along with Renal Insufficiency, Chronic in 3 studies
Quinolinic Acid: A metabolite of tryptophan with a possible role in neurodegenerative disorders. Elevated CSF levels of quinolinic acid are correlated with the severity of neuropsychological deficits in patients who have AIDS.
pyridinedicarboxylic acid : Any member of the class of pyridines carrying two carboxy groups.
quinolinic acid : A pyridinedicarboxylic acid that is pyridine substituted by carboxy groups at positions 2 and 3. It is a metabolite of tryptophan.
Renal Insufficiency, Chronic: Conditions in which the KIDNEYS perform below the normal level for more than three months. Chronic kidney insufficiency is classified by five stages according to the decline in GLOMERULAR FILTRATION RATE and the degree of kidney damage (as measured by the level of PROTEINURIA). The most severe form is the end-stage renal disease (CHRONIC KIDNEY FAILURE). (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We aimed to determine the effect of quinolinic acid (QA) on hemostasis in rat and mouse models of thrombosis." | 7.91 | Effect of quinolinic acid - A uremic toxin from tryptophan metabolism - On hemostatic profile in rat and mouse thrombosis models. ( Chabielska, E; Kamiński, T; Kramkowski, K; Leszczyńska, A; Marcińczyk, N; Misztal, T; Pawlak, D, 2019) |
| "We aimed to determine the effect of quinolinic acid (QA) on hemostasis in rat and mouse models of thrombosis." | 3.91 | Effect of quinolinic acid - A uremic toxin from tryptophan metabolism - On hemostatic profile in rat and mouse thrombosis models. ( Chabielska, E; Kamiński, T; Kramkowski, K; Leszczyńska, A; Marcińczyk, N; Misztal, T; Pawlak, D, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leszczyńska, A | 1 |
| Misztal, T | 1 |
| Marcińczyk, N | 1 |
| Kamiński, T | 1 |
| Kramkowski, K | 1 |
| Chabielska, E | 1 |
| Pawlak, D | 1 |
| Baranyi, A | 1 |
| Amouzadeh-Ghadikolai, O | 1 |
| Lewinski, DV | 1 |
| Breitenecker, RJ | 1 |
| Stojakovic, T | 1 |
| März, W | 1 |
| Robier, C | 1 |
| Rothenhäusler, HB | 1 |
| Mangge, H | 1 |
| Meinitzer, A | 1 |
| Schefold, JC | 1 |
| Zeden, JP | 1 |
| Fotopoulou, C | 1 |
| von Haehling, S | 1 |
| Pschowski, R | 1 |
| Hasper, D | 1 |
| Volk, HD | 1 |
| Schuett, C | 1 |
| Reinke, P | 1 |
3 other studies available for quinolinic acid and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
Effect of quinolinic acid - A uremic toxin from tryptophan metabolism - On hemostatic profile in rat and mouse thrombosis models.
Topics: Animals; Fibrinolysis; Hemostasis; Male; Mice; Quinolinic Acid; Rats; Rats, Wistar; Renal Insufficie | 2019 |
Beta-trace Protein as a new non-invasive immunological Marker for Quinolinic Acid-induced impaired Blood-Brain Barrier Integrity.
Topics: Adult; Biomarkers; Blood-Brain Barrier; Female; Glomerular Filtration Rate; Humans; Intramolecular O | 2017 |
Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
Topics: 5-Hydroxytryptophan; Adult; Aged; C-Reactive Protein; Case-Control Studies; Creatinine; Female; Huma | 2009 |